FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2140718047> ?p ?o ?g. }

• W2140718047 endingPage "22" @default.
• W2140718047 startingPage "17" @default.
• W2140718047 abstract "Interferon beta (IFNB) treatment for multiple sclerosis (MS) has been associated with thyroid disorders (TD), in particular in patients with subclinical TD or anti-thyroid (AT) autoantibodies (autoAb) before starting treatment. TD and AT autoAb frequency was reported increased in MS. To determine whether MS patients have subclinical thyroid function abnormalities or anti-thyroid autoimmunity predisposing to develop TD, we performed a prospective multicenter screening of thyroid function and autoimmunity in 152 relapsing–remitting (RR) MS patients selected to receive IFNB treatment and in 437 healthy normothyroidal controls. Thyroid-related hormones and anti-thyroid microsomal antigen (anti-TMA) autoAb were tested with sensitive immunoradiometric or chromatographic assays. Cases were stratified for different progressively decreasing or increasing cutoff values of thyroid-stimulating hormone (TSH) (0.3, 0.2, 0.1, 3 and 5 mIU/l), and odds ratios (OR) with 95% confidence intervals (CI) calculated using logistic regression adjusted for gender, age, and anti-TMA autoAb positivity. The frequency of cases below or above the TSH cutoff values was not significantly different in MS patients and controls, and the risk to have an abnormal TSH level was not significantly increased in MS patients (OR ranging 0.37–0.84; CI, 0.05–3.01), even if anti-TMA autoAb positive (OR ranging 0.35–0.85; CI, 0.04–3.00). Frequencies of subclinical hypothyroidism and of anti-TMA autoAb positivity were, however, trending higher in MS men (ranging 5–7%) than in controls (3%). MS patients do not have an increased risk of subtle thyroid function abnormalities, subclinical TD, or anti-TMA autoAb positivity that may predispose to develop thyroid dysfunction during IFNB treatment. The positive trend for subclinical hypothyroidism and anti-TMA autoAb positivity, however, advises a longitudinal study of thyroid function and autoimmunity during IFNB treatment to see whether patients with baseline subclinical thyroid dysfunction develop clinically significant alteration during treatment." @default.
• W2140718047 created "2016-06-24" @default.
• W2140718047 creator A5001337711 @default.
• W2140718047 creator A5003621670 @default.
• W2140718047 creator A5005818662 @default.
• W2140718047 creator A5007907892 @default.
• W2140718047 creator A5015671700 @default.
• W2140718047 creator A5022228419 @default.
• W2140718047 creator A5035452574 @default.
• W2140718047 creator A5038835910 @default.
• W2140718047 creator A5071503464 @default.
• W2140718047 creator A5085391978 @default.
• W2140718047 date "2001-12-01" @default.
• W2140718047 modified "2023-10-13" @default.
• W2140718047 title "Thyroid function and anti-thyroid antibodies in MS patients screened for interferon treatment. A multicenter study" @default.
• W2140718047 cites W1964730206 @default.
• W2140718047 cites W1972601584 @default.
• W2140718047 cites W1977454506 @default.
• W2140718047 cites W1991945992 @default.
• W2140718047 cites W2006459679 @default.
• W2140718047 cites W2015441553 @default.
• W2140718047 cites W2020269985 @default.
• W2140718047 cites W2034952563 @default.
• W2140718047 cites W2041790780 @default.
• W2140718047 cites W2048701192 @default.
• W2140718047 cites W2049302669 @default.
• W2140718047 cites W2054247532 @default.
• W2140718047 cites W2056641644 @default.
• W2140718047 cites W2058072615 @default.
• W2140718047 cites W2066467884 @default.
• W2140718047 cites W2078719351 @default.
• W2140718047 cites W2091932183 @default.
• W2140718047 cites W2092599829 @default.
• W2140718047 cites W2097669496 @default.
• W2140718047 cites W2112165124 @default.
• W2140718047 cites W2122733513 @default.
• W2140718047 cites W2130355701 @default.
• W2140718047 cites W2133547068 @default.
• W2140718047 cites W2148113299 @default.
• W2140718047 cites W2156187710 @default.
• W2140718047 cites W2158036365 @default.
• W2140718047 cites W4237591498 @default.
• W2140718047 cites W4246368399 @default.
• W2140718047 doi "https://doi.org/10.1016/s0022-510x(01)00637-2" @default.
• W2140718047 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11718745" @default.
• W2140718047 hasPublicationYear "2001" @default.
• W2140718047 type Work @default.
• W2140718047 sameAs 2140718047 @default.
• W2140718047 citedByCount "32" @default.
• W2140718047 countsByYear W21407180472012 @default.
• W2140718047 countsByYear W21407180472014 @default.
• W2140718047 countsByYear W21407180472015 @default.
• W2140718047 countsByYear W21407180472017 @default.
• W2140718047 countsByYear W21407180472021 @default.
• W2140718047 countsByYear W21407180472022 @default.
• W2140718047 countsByYear W21407180472023 @default.
• W2140718047 crossrefType "journal-article" @default.
• W2140718047 hasAuthorship W2140718047A5001337711 @default.
• W2140718047 hasAuthorship W2140718047A5003621670 @default.
• W2140718047 hasAuthorship W2140718047A5005818662 @default.
• W2140718047 hasAuthorship W2140718047A5007907892 @default.
• W2140718047 hasAuthorship W2140718047A5015671700 @default.
• W2140718047 hasAuthorship W2140718047A5022228419 @default.
• W2140718047 hasAuthorship W2140718047A5035452574 @default.
• W2140718047 hasAuthorship W2140718047A5038835910 @default.
• W2140718047 hasAuthorship W2140718047A5071503464 @default.
• W2140718047 hasAuthorship W2140718047A5085391978 @default.
• W2140718047 hasConcept C113280763 @default.
• W2140718047 hasConcept C126322002 @default.
• W2140718047 hasConcept C134018914 @default.
• W2140718047 hasConcept C156957248 @default.
• W2140718047 hasConcept C159654299 @default.
• W2140718047 hasConcept C163764329 @default.
• W2140718047 hasConcept C180650514 @default.
• W2140718047 hasConcept C203014093 @default.
• W2140718047 hasConcept C2778840127 @default.
• W2140718047 hasConcept C2993291352 @default.
• W2140718047 hasConcept C50181227 @default.
• W2140718047 hasConcept C526584372 @default.
• W2140718047 hasConcept C71924100 @default.
• W2140718047 hasConcept C90924648 @default.
• W2140718047 hasConceptScore W2140718047C113280763 @default.
• W2140718047 hasConceptScore W2140718047C126322002 @default.
• W2140718047 hasConceptScore W2140718047C134018914 @default.
• W2140718047 hasConceptScore W2140718047C156957248 @default.
• W2140718047 hasConceptScore W2140718047C159654299 @default.
• W2140718047 hasConceptScore W2140718047C163764329 @default.
• W2140718047 hasConceptScore W2140718047C180650514 @default.
• W2140718047 hasConceptScore W2140718047C203014093 @default.
• W2140718047 hasConceptScore W2140718047C2778840127 @default.
• W2140718047 hasConceptScore W2140718047C2993291352 @default.
• W2140718047 hasConceptScore W2140718047C50181227 @default.
• W2140718047 hasConceptScore W2140718047C526584372 @default.
• W2140718047 hasConceptScore W2140718047C71924100 @default.
• W2140718047 hasConceptScore W2140718047C90924648 @default.
• W2140718047 hasIssue "1" @default.
• W2140718047 hasLocation W21407180471 @default.
• W2140718047 hasLocation W21407180472 @default.

• next